CEZARY DUDZINSKI
Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Psychiatry PALOS HEIGHTS, IL NPI 1487841540
Browse related groups: Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Psychiatry IL ABBVIE INC. All categories
General Payments — all program years on this page
$673.11
- Category: General Payments
- Program years: PY2018–2021
- Record count: 36
- As of (CMS publication): 2026-01-23
Latest program year (PY2021): $164.57 across 9 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2021) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $164.57 | 9 |
By paying entity
Latest program year (PY2021) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $51.75 | 4 |
| Janssen Pharmaceuticals, Inc | $44.75 | 2 |
| Vanda Pharmaceuticals Inc. | $34.00 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $18.53 | 1 |
| ITI, Inc. | $15.54 | 1 |
By program year
Records — PY2021 (9)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 788310057 | Janssen Pharmaceuticals, Inc | $21.21 | 05/19/2021 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 788310059 | Janssen Pharmaceuticals, Inc | $23.54 | 02/04/2021 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 794383049 | AbbVie Inc. | $11.30 | 03/17/2021 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 794383051 | AbbVie Inc. | $14.63 | 04/16/2021 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 794383053 | AbbVie Inc. | $11.84 | 04/28/2021 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 794383055 | AbbVie Inc. | $13.98 | 05/11/2021 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 819916107 | Takeda Pharmaceuticals U.S.A., Inc. | $18.53 | 03/17/2021 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 830130155 | ITI, Inc. | $15.54 | 04/28/2021 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 838898455 | Vanda Pharmaceuticals Inc. | $34.00 | 04/28/2021 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2021_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.